Aurora kinase A induces migration and invasion by inducing epithelial-to-mesenchymal transition in colon cancer cells |
Hong, On-Yu
(Department of Biochemistry, Institute for Medical Sciences, Jeonbuk National University Medical School)
Kang, Sang Yull (Department of Surgery, Research Institute of Clinical Medicine of Jeonbuk National University and Biomedical Research Institute of Jeonbuk National University Hospital) Noh, Eun-Mi (Department of Biochemistry, Institute for Medical Sciences, Jeonbuk National University Medical School) Yu, Hong-Nu (Department of Biochemistry, Institute for Medical Sciences, Jeonbuk National University Medical School) Jang, Hye-Yeon (Department of Biochemistry, Institute for Medical Sciences, Jeonbuk National University Medical School) Kim, Seong-Hun (Division of Gastroenterology, Department of Internal Medicine, Research Institute of Clinical Medicine, Jeonbuk National University Medical School and Hospital) Hong, Jingyu (Department of Anesthesiology and Pain Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea) Chung, Eun Yong (Department of Anesthesiology and Pain Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea) Kim, Jong-Suk (Department of Biochemistry, Institute for Medical Sciences, Jeonbuk National University Medical School) |
1 | Masur K, Lang K, Niggemann B, Zanker KS and Entschladen F (2001) High PKC alpha and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells. Mol Biol Cell 12, 1973-1982 DOI |
2 | D'Assoro, AB, Liu T, Quatraro C et al (2014) The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERalpha(+) breast cancer cells. Oncogene 33, 599-610 DOI |
3 | Bauvois B (2012) New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta 1825, 29-36 |
4 | Julien S, Puig I, Caretti E et al (2007) Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26, 7445-7456 DOI |
5 | Privette LM and Petty EM (2008) CHFR: a novel mitotic checkpoint protein and regulator of tumorigenesis. Transl Oncol 1, 57-64 DOI |
6 | Tarafdar A and Michie AM (2014) Protein kinase C in cellular transformation: a valid target for therapy? Biochem Soc Trans 42, 1556-1562 DOI |
7 | Nam EH, Lee Y, Moon B, Lee JW and Kim S (2015) Twist1 and AP-1 cooperatively upregulate integrin alpha5 expression to induce invasion and the epithelial-mesenchymal transition. Carcinogenesis 36, 327-337 DOI |
8 | Steeghs N, Eskens FA, Gelderblom H et al (2009) Phase I pharmacokinetic and pharmacodynamic study of the aurora kinase inhibitor danusertib in patients with advanced or metastatic solid tumors. J Clin Oncol 27, 5094-5101 DOI |
9 | Bakiri L, Macho-Maschler S, Custic I (2015) Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression. Cell Death Differ 22, 336-350 DOI |
10 | Julien S, Puig I, Caretti E et al (2007) Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26, 7445-7456 DOI |
11 | Yu X, Minter-Dykhouse K, Malureanu L et al (2005) Chfr is required for tumor suppression and Aurora A regulation. Nat Genet 37, 401-406 DOI |
12 | Tang A, Gao K, Chu L, Zhang R, Yang J and Zheng J (2017) Aurora kinases: novel therapy targets in cancers. Oncotarget 8, 23937-23954 DOI |
13 | Noh EM, Lee YR, Hong OY, Jung SH, Youn HJ and Kim JS (2015) Aurora kinases are essential for PKC-induced invasion and matrix metalloproteinase-9 expression in MCF-7 breast cancer cells. Oncol Rep 34, 803-810 DOI |
14 | Siegel R, Naishadham D and Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63, 11-30 DOI |
15 | Jemal A, Center MM, DeSantis C and Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19, 1893-1907 DOI |
16 | Thiery JP and Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7, 131-142 DOI |
17 | Batlle E, Sancho E, Franci C et al (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2, 84-89 DOI |
18 | Parekh DB, Ziegler W and Parker PJ (2000) Multiple pathways control protein kinase C phosphorylation. EMBO J 19, 496-503 DOI |
19 | Serova M, Ghoul A, Benhadji KA et al (2006) Preclinical and clinical development of novel agents that target the protein kinase C family. Semin Oncol 33, 466-478 DOI |
20 | D'Assoro AB, Haddad T and Galanis E (2015) Aurora-A kinase as a promising therapeutic target in cancer. Front Oncol 5, 295 DOI |
21 | Mathias RA, Gopal SK and Simpson RJ (2013) Contribution of cells undergoing epithelial-mesenchymal transition to the tumour microenvironment. J Proteomics 78, 545-557 DOI |
22 | Goos JA, Coupe VM, Diosdado B et al (2013) Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis. Br J Cancer 109, 2445-2452 DOI |
23 | Stetler-Stevenson WG (1999) Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 103, 1237-1241 DOI |
24 | Nomura A, Majumder K, Giri B et al (2016) Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer. Lab Invest 96, 1268-1278 DOI |
25 | Carvajal RD, Tse A and Schwartz GK (2006) Aurora kinases: new targets for cancer therapy. Clin Cancer Res 12, 6869-6875 DOI |
26 | Du R, Huang C, Liu K, Li X and Dong Z (2021) Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy. Mol Cancer 20, 15 DOI |
27 | Usman S, Waseem NH, Nguyen TKN et al (2021) Vimentin is at the heart of epithelial mesenchymal transition (emt) mediated metastasis. Cancers (Basel) 13, 4985 DOI |